Rani Therapeutics Holdings, Inc. · NASDAQ:RANI
Imran Talat sold 8,014 Rani Therapeutics Holdings, Inc. shares (Form 4)
Traded Dec 27, 2024 to Jun 27, 2026 · Filed Jul 21, 2026
From Dec 27, 2024 to Jun 27, 2026, Imran Talat (Director, Chief Executive Officer) sold 8,014 Rani Therapeutics Holdings, Inc. shares at US$1.41 for US$11,300, leaving 434,736 shares. Filed Jul 21, 2026 (Form 4).
- Sold
- 8,014 shares
- Price
- US$1.41
- Value
- US$11,300
- Holding after
- 434,736 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Dec 27, 2024 | Class A Common Stock | Sale | 8,014 | US$1.41 | 486,737 | Direct |
| Jun 27, 2025 | Class A Common Stock | Shares withheld for tax | 9,076 | US$0.55 | 477,661 | Direct |
| Sep 27, 2025 | Class A Common Stock | Shares withheld for tax | 9,077 | US$0.48 | 468,584 | Direct |
| Dec 27, 2025 | Class A Common Stock | Shares withheld for tax | 7,906 | US$1.40 | 460,678 | Direct |
| Mar 22, 2026 | Class A Common Stock | Shares withheld for tax | 8,916 | US$1.13 | 451,762 | Direct |
| Mar 27, 2026 | Class A Common Stock | Shares withheld for tax | 9,099 | US$0.81 | 442,663 | Direct |
| Jun 27, 2026 | Class A Common Stock | Shares withheld for tax | 7,927 | US$0.74 | 434,736 | Direct |
Source
Related
- Rani Therapeutics Holdings, Inc.
- Imran Talat
- Rani Therapeutics Holdings, Inc. shareholders
- Form 4 · Imran Talat · Sep 29, 2026
- Form 4 · Imran Talat · Jul 21, 2026
- Form 4 · Javadi Alireza · Sep 29, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Imran Mir A · Jul 23, 2026
- Form 4 · Javadi Alireza · Jul 21, 2026